Cargando…
Moxifloxacin rescues SMA phenotypes in patient-derived cells and animal model
Spinal muscular atrophy (SMA) is a genetic disease resulting in the loss of α-motoneurons followed by muscle atrophy. It is caused by knock-out mutations in the survival of motor neuron 1 (SMN1) gene, which has an unaffected, but due to preferential exon 7 skipping, only partially functional human-s...
Autores principales: | Januel, Camille, Menduti, Giovanna, Mamchaoui, Kamel, Martinat, Cecile, Artero, Ruben, Konieczny, Piotr, Boido, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304069/ https://www.ncbi.nlm.nih.gov/pubmed/35864358 http://dx.doi.org/10.1007/s00018-022-04450-8 |
Ejemplares similares
-
Recent Advances in High-Content Imaging and Analysis in iPSC-Based Modelling of Neurodegenerative Diseases
por: Menduti, Giovanna, et al.
Publicado: (2023) -
Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment
por: Menduti, Giovanna, et al.
Publicado: (2020) -
Expression of Muscle-Specific MiRNA 206 in the Progression of Disease in a Murine SMA Model
por: Valsecchi, Valeria, et al.
Publicado: (2015) -
Modelling of SMA Vibration Systems in an AVA Example
por: Rączka, Waldemar, et al.
Publicado: (2021) -
DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via a subcutaneous administration
por: Aslesh, Tejal, et al.
Publicado: (2023)